Replies to post #795455 on NorthWest Biotherapeutics Inc (NWBO)

[Doc logic]

jesster64,

More likely up listing consultants that came right out and said the timing was off and to get back to them when the timing looked better. That’s what I would have said and I’m not even a consultant; ). If I was hired now as a consultant I’d be asking about manufacturing at commercial scale readiness and whether or not a defined source and quantity of expected investment or revenue stream vs expected expenditures analysis shows net positive in any reasonable amount of time based on developing a positive ROI either through increased value of assets for book value or increasing revenue stream from actual sales and reimbursement within one year. No sense uplisting only to crash and burn. Best wishes.

[KRISGO]

Jesster, I copied the below comment from a user/investor named Steve Pacifica on Change.org. Any idea who Darren Weingrow is or what he does?

Northwest Bio and its Officers have shown zero regard for its investors and have not acted in their best interest. For years investors have suffered through endless dilution, secrecy, constant excuses, half truths and lack of transparency. Over promise and underperform has been the mantra with management. Years post data lock and we still only have one regulatory submission and no partnerships or institutional investors. On another note, what does the company pay Darren Weingrow for? He has been on payroll for years as an investor relations representative yet no one knows what he has done or what he is compensated for. It is rumored that he oversees multiple social media accounts that were created to pump the stock when in fact it has had the opposite effect on the share price. Investors deserve better and if management cannot deliver value they should step down.